Nicorandil lipid microsphere preparation and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 太阳升(亳州)生物医药科技有限公司
- Publication Date
- 2019-08-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the field of pharmaceutical dosage forms, in particular to a nicorandil lipid microsphere preparation and a preparation method thereof. Background technique
[0002] Nicorandil is a coronary vasodilator used in the treatment of various cardiovascular diseases. It not only has the effect of nitrate ester drugs to expand coronary blood vessels and continuously increase coronary blood flow, but also prevents the release of calcium ions in cells and increases the permeability of cell membranes to potassium ions.
[0003] However, the physical properties of Nicorandil are not stable enough. Nicorandil solid dosage forms are prone to degradation of active drugs when conditions such as humidity, temperature, oxygen, light, acidity, etc. are not suitable. Summary of the invention
[0004] The main purpose of the embodiments of the present invention is to provide a nicorandil lipid microsphere preparation and a preparation method thereof to s...